Pure primary ovarian squamous cell carcinoma: A case report and review of the literature

  • Authors:
    • Jung-Woo Park
    • Jong Woon Bae
  • View Affiliations

  • Published online on: October 31, 2014     https://doi.org/10.3892/ol.2014.2650
  • Pages: 321-323
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Pure primary ovarian squamous cell carcinoma (SCC) is a rare lesion that usually arises from the malignant transformation of an existing ovarian dermoid cyst. The de novo occurrence of an ovarian SCC in the absence of a prior ovarian dermoid cyst, Brenner tumor or endometriosis is extremely rare. At present, no effective therapy exists for treating pure primary ovarian SCC. The present case study describes a patient that presented with progressive coughing, who was diagnosed with an International Federation of Gynecology and Obstetrics stage IV pure primary ovarian SCC with lung metastases. The patient received postoperative chemotherapy, however, the patient succumbed to the disease. The current study also presents a review of the literature.

Introduction

The incidence of a pure primary ovarian squamous cell carcinoma (SCC) is extremely rare when not associated with pre-existing ovarian lesions, such as dermoid cysts, Brenner tumors or endometriosis (whose presence is normally indicative of ovarian SCC) (1). To date, only 30 cases of pure primary ovarian SCC have been reported worldwide. Due to the rarity of pure primary ovarian SCC, the clinical features of the disease have not been established and effective treatments are yet to be identified. Subsequent to optimal tumor devulking, patients with early-stage pure primary ovarian SCC may remain disease-free. However, those patients with advanced-stage disease may experience a poorer outcome, despite treatment with postoperative chemotherapy and/or radiotherapy. The present case study describes a patient with pure primary ovarian SCC, and presents a review of the literature. Written informed consent was obtained from the patient’s family.

Case report

A 46-year-old female (gravida 3, para 2) was referred to the Department of Pulmonary Medicine (Dong-A University, College of Medicine, Busan, Republic of Korea) with a history of progressive coughing that had been apparent for three months. Upon chest computed tomography (CT), performed at a local clinic on February 11, 2012, a diagnosis of lung cancer was suspected. The patient was immediately hospitalized and underwent bronchoscopy. A transbronchial lung biopsy revealed an SCC of unknown primary site.

To locate the primary site of the metastatic lung cancer, an abdominal CT and positron emission tomography-CT scan was performed. The results of the scans revealed a left-sided pelvic mass, a left hydronephrosis and multiple regions of lymph node metastasis in the pelvic, abdominal, mediastinal and supraclavicular areas.

The patient was referred to the Department of Obstetrics and Gynecology (Dong-A University, College of Medicine) for gynecological treatment. Abdominal exploration was performed on February 24, 2012, which revealed that the solid mass arose from the left adnexal area, was densely adhered to the sigmoid colon and external iliac vessel, and was encapsulating the left ureter. A total abdominal hysterectomy, bilateral salpingo-oophorectomy, adhesiolysis between the tumor and sigmoid colon, segmental resection of the sigmoid colon and reanastomosis were performed. Following segmental resection, the patient underwent an end-to-end anastomosis of the left ureter.

Histopathological analysis confirmed a pure SCC arising from the left ovary. The pathological results were notable for the absence of any associated dermoid cyst or features suggestive of endometriosis, (Fig. 1). The patient was subsequently diagnosed with stage IVB pure primary ovarian SCC with lung metastases according to the International Federation of Gynecology and Obstetrics staging system (2). Following surgery, the patient was administered a six-course adjuvant chemotherapy regimen, consisting of paclitaxel (175 mg/m2) and carboplatin (5 mg/ml/min) at three-week intervals. Despite the initiation of first-line adjuvant chemotherapy, clinical and radiographical evidence identified tumor progression and aggravation of the lung metastasis. Therefore, a second-line three-course chemotherapy regimen, consisting of topotecan (1 mg/m2) and cisplatin (50 mg/m2) at three-week intervals, and a third-line three-course regimen, consisting of etoposide and ifosfamide at three-week intervals, was administered. Despite this, treatment was unsuccessful and the patient succumbed to the disease on February 12, 2013, following cardiopulmonary arrest.

Discussion

Primary ovarian SCC is rare, with the majority of cases preceded by dermoid cysts. Alternatively, cases of primary ovarian SCC may be associated with Brenner tumors and endometriosis (3). Ovarian SCCs that are reported to arise within a dermoid cyst appear to be incidental histological findings (4). In total, ~2% of cases of primary ovarian SCC originate from the malignant transformation of a dermoid cyst (5). A previous study of metastatic ovarian tumors revealed that a total of 2.5% are of the squamous cell type, with the majority of cases of metastatic SCC originating by direct extension from the cervix (6). Furthermore, of the reported cases of pure ovarian SCC, the most significant association identified was with cervical dysplasia (7,8). However, this association was not identified in the present case study, as revealed by a negative pre-operative pap smear and by post-operative pathological analysis. The incidence of pure primary ovarian SCC is extremely low, with thirty cases described by previous studies (Table I) (1,3,721). Previous studies revealed that stage and grade of tumors correlate with overall survival in pure primary ovarian SCC patients. Thus, patients with early-stage pure primary ovarian SCC may remain disease-free after optimal debulking. However, those patients with advanced-stage disease may experience a poorer outcome, despite treatment with post-operative chemotherapy and/or radiotherapy (7). Due to the rare nature of pure primary ovarian SCC, effective adjuvant chemotherapy or radiotherapy regimens have not yet been established. In the present case study, the patient was unresponsive to the chemotherapy regimen administered following surgical debulking. In the twelfth month subsequent to surgery, the patient succumbed to the rapidly-progressive disease. The chemotherapy regimens administered in the present study, or the doses used, may be unsuitable for this ovarian malignant cell type. Therefore, to identify effective therapies for the treatment of pure primary ovarian SCC, further clinical investigations are required.

Table I

Clinicopathological features of pure primary squamous cell carcinoma reported in the literature.

Table I

Clinicopathological features of pure primary squamous cell carcinoma reported in the literature.

First author/s (ref.)YearCaseAge, yearsFIGO stageGradeTreatmentFollow-up, months
Genadry et al (11)1979141CIS1TAH, BSONR
McGrady et al (12)1993253CIS1TAH, BSOAlive
Sworn et al (13)1995339CIS3TAH, BSOAlive, 60
Yetman and Dudzinski (8)1989433I2TAH, BSOAlive, 15.6
Black and Benitez (14)1964535I1TAH, BSONR
Shingleton et al (15)1974654I1RO, RTDOD, 6
Mai et al (16)1996740I2TAH, BSONR
Macko and Johnson (17)1983890I2UOAlive, 30
Chen (18)1988949I1TAH, BSO, RTAlive, 12
Balat et al (19)20011040IBNRTAH, BSO, PLND, appendectomy, right nephrectomy, chemotherapyDOD, 24
Kashimura et al (9)19891161IINRTAH, BSO, RT, chemotherapyDOD, 9
1242IIINRLSO, RTDOD, 8
1350INRTAH, BSO, RTAlive, 14.4
Pins et al (7)19961473IIA3TAH, BSO, RTDOD, 49
1561IIB3TAH, BSO, RT, chemotherapyAlive, 60
1655IIB3TAH, BSO, TD, chemotherapyAlive, 30
1738IIC3TAH, BSO, chemotherapyDOD, 8
1864IB2RSO, LOAWD, 60
1955IIIB3TAH, BSO, chemotherapyDOD, 2
2052IIIC3Ovarian, omental biopsyNR
2146IIIC3Ovarian, omental biopsyNR
2227IIIC3TAH, BSO, chemotherapyDOD, 1
2370IIIC3TAH, BSO, chemotherapyDOD, 5
2473IV3LSO, RTDOD, 1
Ben-Baruch et al (3)19882565III2TAH, BSO, iliectomy, TD, chemotherapyDOD, 6
Amjad and Pal (20)20082631IIIC1TAH, BSO, TO, bowel resection, chemotherapyAWD, 1
Radhi and Awad (10)19902764IV2TDDOD, 9 days
Chien et al (21)20052863IV3TAH, BSO, PLND, TO, TDDOD, 7
Park et al (1)20102976IIC1TAH, BSO, PLND, PALND, TO, appendectomy, chemotherapyAlive, 42
3048IV2TAH, BSO, PLND, PALND, TO, appendectomy, chemotherapyAlive, 6
Present case20143146IVB2TAH, BSO, TD, bowel resectionDOD, 12

[i] FIGO, International Federation of Gynecology and Obstetrics; TAH, total abdominal hysterectomy; BSO, bilateral salpingo-oophorectomy; RO, right oophorectomy; RT, radiation therapy; UO, unilateral oophorectomy; PLND, pelvic lymph node dissection; LSO, left salpingo-oophorectomy; TD, tumor debulking; RSO, right salpingo-oophorectomy; LO, left oophorectomy; TO, total omentectomy; PALND, para-aortic lymph node dissection; NR, not recorded; DOD, died of disease; AWD, alive with disease; CIS, carcinoma in situ.

References

1 

Park JY, Song JS, Choi G, Kim JH and Nam JH: Pure primary squamous cell carcinoma of the ovary: a report of two cases and review of the literature. Int J Gynecol Pathol. 29:328–334. 2010. View Article : Google Scholar : PubMed/NCBI

2 

Mutch DG and Prat J: 2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer. Gynecol Oncol. 133:401–404. 2014. View Article : Google Scholar : PubMed/NCBI

3 

Ben-Baruch G, Menashe Y, Herczeg E and Menczer J: Pure primary ovarian squamous cell carcinoma. Gynecol Oncol. 29:257–262. 1988. View Article : Google Scholar : PubMed/NCBI

4 

Dos Santos L, Mok E, Iasonos A, et al: Squamous cell carcinoma arising in mature cystic teratoma of the ovary: a case series and review of the literature. Gynecol Oncol. 105:321–324. 2007. View Article : Google Scholar : PubMed/NCBI

5 

Peterson WF: Malignant degeneration of benign cystic teratomas of the ovary; a collective review of the literature. Obstet Gynecol Surv. 12:793–830. 1957. View Article : Google Scholar : PubMed/NCBI

6 

Webb MJ, Decker DG and Mussey E: Cancer metastatic to the ovary: factors influencing survival. Obstet Gynecol. 45:391–396. 1975.PubMed/NCBI

7 

Pins MR, Young RH, Daly WJ and Scully RE: Primary squamous cell carcinoma of the ovary. Report of 37 cases. Am J Surg Pathol. 20:823–833. 1996. View Article : Google Scholar : PubMed/NCBI

8 

Yetman TJ and Dudzinski MR: Primary squamous carcinoma of the ovary: a case report and review of the literature. Gynecol Oncol. 34:240–243. 1989. View Article : Google Scholar : PubMed/NCBI

9 

Kashimura M, Shinohara M, Hirakawa T, Kamura T and Matsukuma K: Clinicopathologic study of squamous cell carcinoma of the ovary. Gynecol Oncol. 34:75–79. 1989. View Article : Google Scholar : PubMed/NCBI

10 

Radhi JM and Awad SM: Bilateral squamous cell carcinoma of the ovary. Case report. Br J Obstet Gynaecol. 97:855–856. 1990. View Article : Google Scholar : PubMed/NCBI

11 

Genadry R, Parmley T and Woodruff JD: Secondary malignancies in benign cystic teratomas. Gynecol Oncol. 8:246–251. 1979. View Article : Google Scholar : PubMed/NCBI

12 

McGrady BJ, Sloan JM, Lamki H and Fox H: Bilateral ovarian cysts with squamous intraepithelial neoplasia. Int J Gynecol Pathol. 12:350–354. 1993. View Article : Google Scholar : PubMed/NCBI

13 

Sworn MJ, Jones H, Letchworth AT, Herrington CS and McGee JO: Squamous intraepithelial neoplasia in an ovarian cyst, cervical intraepithelial neoplasia, and human papillomavirus. Hum Pathol. 26:344–347. 1995. View Article : Google Scholar : PubMed/NCBI

14 

Black WC and Benitez RE: Nonteratomatous squamous-cell carcinoma in situ of the ovary. Obstet Gynecol. 24:865–868. 1964.PubMed/NCBI

15 

Shingleton HM, Middleton FF and Gore H: Squamous cell carcinoma in the ovary. Am J Obstet Gynecol. 120:556–560. 1974.PubMed/NCBI

16 

Mai KT, Yazdi HM, Bertrand MA, LeSaux N and Cathcart LL: Bilateral primary ovarian squamous cell carcinoma associated with human papilloma virus infection and vulvar and cervical intraepithelial neoplasia. A case report with review of the literature. Am J Surg Pathol. 20:767–772. 1996. View Article : Google Scholar : PubMed/NCBI

17 

Macko MB and Johnson LA: Primary squamous ovarian carcinoma. A case report and review of the literature. Cancer. 52:1117–1119. 1983. View Article : Google Scholar : PubMed/NCBI

18 

Chen KT: Squamous cell carcinoma of the ovary. Arch Pathol Lab Med. 112:114–115. 1988.PubMed/NCBI

19 

Balat O, Aydin A, Camci C, Kutlar I and Büyükberber S: Bilateral primary squamous cell carcinoma of the ovary: a case report of isolated metastasis to the lateral pelvic wall. Eur J Gynaecol Oncol. 22:445–446. 2001.

20 

Amjad AI and Pal I: De novo primary squamous cell carcinoma of the ovary: a case of a rare malignancy with an aggressive clinical course. J Pak Med Assoc. 58:272–274. 2008.PubMed/NCBI

21 

Chien SC, Sheu BC, Chang WC, Wu MZ and Huang SC: Pure primary squamous cell carcinoma of the ovary: a case report and review of the literature. Acta Obstet Gynecol Scand. 84:706–708. 2005. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

January-2015
Volume 9 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Park J and Park J: Pure primary ovarian squamous cell carcinoma: A case report and review of the literature. Oncol Lett 9: 321-323, 2015
APA
Park, J., & Park, J. (2015). Pure primary ovarian squamous cell carcinoma: A case report and review of the literature. Oncology Letters, 9, 321-323. https://doi.org/10.3892/ol.2014.2650
MLA
Park, J., Bae, J. W."Pure primary ovarian squamous cell carcinoma: A case report and review of the literature". Oncology Letters 9.1 (2015): 321-323.
Chicago
Park, J., Bae, J. W."Pure primary ovarian squamous cell carcinoma: A case report and review of the literature". Oncology Letters 9, no. 1 (2015): 321-323. https://doi.org/10.3892/ol.2014.2650